Outpatient Stem Cell Mobilization with Intermediate-Dose Cyclophosphamide Is a Safe and Effective Procedure

被引：0
|
作者：
Pompa, Alessandra [1 ]
Gregorini, Anna Ines [1 ]
Guidotti, Francesca [1 ,2 ]
Goldaniga, Maria Cecilia [1 ]
Rossi, Francesca Gaia [1 ]
Marcolin, Riccardo [1 ,2 ]
Baldini, Luca [1 ,2 ]
Cortelezzi, Agostino [1 ,2 ]
机构：
[1] Fondazione Ca Granda IRCCS Osped Maggiore Policli, OncoHematol Unit, Milan, Italy
[2] Univ Milan, Milan, Italy
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.5734.5734
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5734
引用
收藏
页数：6
相关论文
共 50 条
  • [1] OUTPATIENT STEM CELL MOBILIZATION WITH INTERMEDIATE-DOSE CYCLOPHOSPHAMIDE IS A SAFE AND EFFECTIVE PROCEDURE
    Pompa, A.
    Guidotti, F.
    Mometto, G.
    Goldaniga, M.
    Rossi, F.
    Marcolin, R.
    Baldini, L.
    Cortelezzi, A.
    [J]. HAEMATOLOGICA, 2016, 101 : 785 - 785
  • [2] Outpatient Stem Cell Mobilization with Low and Intermediate Dose Cyclophosphamide Is a Safe and Effective Procedure in Newly Diagnosed Multiple Myeloma Patients Eligible for Stem Cell Transplantation
    Pompa, Alessandra
    Paris, Laura
    Guidotti, Francesca
    Ferla, Valeria
    Galli, Monica
    Rambaldi, Alessandro
    Baldini, Luca
    Cortelezzi, Agostino
    [J]. BLOOD, 2017, 130
  • [3] Safety of outpatient stem cell mobilization with low- or intermediate-dose cyclophosphamide in newly diagnosed multiple myeloma patients
    Pompa, Alessandra
    Pettine, Loredana
    Giannarelli, Diana
    Paris, Laura
    Torretta, Lorella
    Cavallaro, Francesca
    Levati, Giorgia Virginia
    Stefanoni, Paola
    Mocellin, Cristina
    Galli, Monica
    Baldini, Luca
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 107 (05) : 566 - 572
  • [4] Intermediate-dose cyclophosphamide and bortezomib for PBSC mobilization in multiple myeloma
    Sawazaki, Aiko
    Sugimori, Chiharu
    Yamaguchi, Masaki
    Nakao, Shinji
    [J]. TRANSFUSION AND APHERESIS SCIENCE, 2023, 62 (03)
  • [5] Failure of the addition of methylprednisolone to intermediate-dose cyclophosphamide and lenograstim for stem cell mobilization to make the timing of PBSC harvesting more predictable
    C E Rudin
    J Melhuish
    J Hall
    [J]. Bone Marrow Transplantation, 2007, 40 : 293 - 294
  • [6] Failure of the addition of methylprednisolone to intermediate-dose cyclophosphamide and lenograstim for stem cell mobilization to make the timing of PBSC harvesting more predictable
    Rudin, C. E.
    Melhuish, J.
    Hall, J.
    [J]. BONE MARROW TRANSPLANTATION, 2007, 40 (03) : 293 - 294
  • [7] INTERMEDIATE-DOSE VERSUS LOW-DOSE CYCLOPHOSPHAMIDE FOR AUTOLOGOUS PERIPHERAL BLOOD STEM CELL MOBILIZATION IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS
    Mancuso, K.
    Montefusco, V.
    Bringhen, S.
    Tacchetti, P.
    Offidani, M.
    Ballanti, S.
    La Nasa, F.
    Dominietto, A.
    Dozza, L.
    Aglietta, M.
    Pisane, F.
    Quintini, G.
    Zannetti, B.
    Martello, M.
    Fregoni, V.
    Sonneveld, P.
    Cavo, M.
    [J]. HAEMATOLOGICA, 2017, 102 : 23 - 23
  • [8] MOBILIZATION OF CIRCULANTING STEM-CELLS ON AN OUTPATIENT BASIS WITH A SINGLE INTERMEDIATE-DOSE (4G/M(2)) CYCLOPHOSPHAMIDE AND G-CSF
    LIBERTI, G
    INDOVINA, A
    BUSCEMI, F
    GENTILE, S
    SCIME, R
    MALLEO, C
    VASTA, S
    PAMPINELLA, M
    SANTORO, A
    MAJOLINO, I
    [J]. EXPERIMENTAL HEMATOLOGY, 1993, 21 (08) : 1169 - 1169
  • [9] STEM CELL MOBILIZATION EFFICIENCY OF HIGH DOSE CYCLOPHOSPHAMIDE COMPARED TO INTERMEDIATE DOSE CYCLOPHOSPHAMIDE IN MULTIPLE MYELOMA PATIENTS
    Colasante, F.
    Schiavo, D.
    Ferreri, A.
    Rinaldi, C.
    Savignano, C.
    Patriarca, F.
    Fanin, R.
    [J]. HAEMATOLOGICA, 2017, 102 : 135 - 135
  • [10] Vinorelbine plus intermediate dose cyclophosphamide is an effective and safe regimen for the mobilization of peripheral blood stem cells in patients with multiple myeloma
    Annunziata, M
    Celentano, M
    Pocali, B
    D'Amico, MR
    Palmieri, S
    Viola, A
    Copia, C
    Falco, C
    Del Vecchio, L
    Ferrara, F
    [J]. ANNALS OF HEMATOLOGY, 2006, 85 (06) : 394 - 399
12345